VEZF1 loss-of-function mutation underlying familial dilated cardiomyopathy

• Published in: European journal of medical genetics 2023-03, Vol.66 (3), p.104705-104705, Article 104705
• Main Authors: Shi, Hong-Yu, Xie, Meng-Shi, Guo, Yu-Han, Yang, Chen-Xi, Gu, Jia-Ning, Qiao, Qi, Di, Ruo-Min, Qiu, Xing-Biao, Xu, Ying-Jia, Yang, Yi-Qing
• Format: Article
• Language: English
• Subjects: Cardiomyopathy, Dilated - genetics; Cardiomyopathy, Dilated - pathology; Dilated cardiomyopathy; DNA-Binding Proteins - genetics; Genetics; Heterozygote; Humans; Mutation; Pedigree; Reporter gene assay; Transcription factor; Transcription Factors - genetics; Transcription Factors - metabolism; VEZF1
• ISSN: 1769-7212; 1878-0849
• DOI: 10.1016/j.ejmg.2023.104705

Dilated cardiomyopathy (DCM), characteristic of left ventricular or biventricular dilation with systolic dysfunction, is the most common form of cardiomyopathy, and a leading cause of heart failure and sudden cardiac death. Aggregating evidence highlights the underlying genetic basis of DCM, and mutations in over 100 genes have been causally linked to DCM. Nevertheless, due to pronounced genetic heterogeneity, the genetic defects underpinning DCM in most cases remain obscure. Hence, this study was sought to identify novel genetic determinants of DCM. In this investigation, whole-exome sequencing and bioinformatics analyses were conducted in a family suffering from DCM, and a novel heterozygous mutation in the VEZF1 gene (coding for a zinc finger-containing transcription factor critical for cardiovascular development and structural remodeling), NM_007146.3: c.490A > T; p.(Lys164*), was identified. The nonsense mutation was validated by Sanger sequencing and segregated with autosome-dominant DCM in the family with complete penetrance. The mutation was neither detected in another cohort of 200 unrelated DCM patients nor observed in 400 unrelated healthy individuals nor retrieved in the Single Nucleotide Polymorphism database, the Human Gene Mutation Database and the Genome Aggregation Database. Biological analyses by utilizing a dual-luciferase reporter assay system revealed that the mutant VEZF1 protein failed to transactivate the promoters of MYH7 and ET1, two genes that have been associated with DCM. The findings indicate VEZF1 as a new gene responsible for DCM, which provides novel insight into the molecular pathogenesis of DCM, implying potential implications for personalized precisive medical management of the patients affected with DCM.